BNF:

8.3.4.2

Status:

Amber

Decision Date:

September 2016

Comments

Degarelix may be prescribed for patients requiring a rapid lowering of testosterone presenting with symptoms such as impending spinal cord compression (as per NICE TA404) or renal failure due to ureteric obstruction.  See shared care guideline.

Amber Drug Classifications

• 1: Requiring specialist assessment to enable patient selection and initiation of treatment
• 2: Requiring short or medium term (e.g. 3-6 months) specialist monitoring of efficacy or until the patient is stable

search again